Mitochondrial DNA Methylation as a Predictor of Immunotherapy Outcomes and Prognosis in Lung Adenocarcinoma: Insights from Single-Cell RNA Sequencing and Machine Learning Approaches - Quiz - MDSpire

Mitochondrial DNA Methylation as a Predictor of Immunotherapy Outcomes and Prognosis in Lung Adenocarcinoma: Insights from Single-Cell RNA Sequencing and Machine Learning Approaches

  • By

  • Jian Ding

  • Gang Cheng

  • Qian Xue

  • Weizhen Guo

  • Yikun Cheng

  • Cheng Yang

  • Jiabing Tong

  • Zegeng Li

  • Yating Gao

  • February 10, 2026

  • 0 min

Share

Original Source(s)

Mitochondrial DNA Methylation as a Predictor of Immunotherapy Outcomes and Prognosis in Lung Adenocarcinoma: Insights from Single-Cell RNA Sequencing and Machine Learning Approaches

  • by Jian Ding, Gang Cheng, Qian Xue, Weizhen Guo, Yikun Cheng, Cheng Yang, Jiabing Tong, Zegeng Li, Yating Gao

  • February 10, 2026

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

FOXA2 in cancer: from fundamental biology to clinical translation

Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy